| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1019228118 |
| P356 | DOI | 10.1038/JHH.2010.102 |
| P953 | full work available at URL | https://www.nature.com/articles/jhh2010102.pdf |
| https://www.nature.com/articles/jhh2010102 | ||
| P698 | PubMed publication ID | 21068764 |
| P2093 | author name string | R. D. Gordon | |
| A. H. Ahmed | |||
| D. Robson | |||
| M. Stowasser | |||
| D. Cowley | |||
| E. Pimenta | |||
| C. Kogovsek | |||
| P2860 | cites work | Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure | Q22306384 |
| Systematic review: diagnostic procedures to differentiate unilateral from bilateral adrenal abnormality in primary aldosteronism | Q33498721 | ||
| Nephrotoxicity of increased glomerular protein traffic | Q33539422 | ||
| Diagnosis and management of primary aldosteronism | Q34553618 | ||
| Proteinuria, impaired kidney function, and adverse outcomes in people with coronary disease: analysis of a previously conducted randomised trial | Q34683498 | ||
| Central regulation of sodium appetite. | Q34709498 | ||
| Aldosterone-induced organ damage: plasma aldosterone level and inappropriate salt status | Q35805905 | ||
| Aldosterone in the development and progression of renal injury | Q35807297 | ||
| Primary aldosteronism: diagnosis and treatment | Q36684808 | ||
| Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system | Q37087344 | ||
| Dietary salt intake, salt sensitivity, and cardiovascular health | Q37182402 | ||
| Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline | Q37190775 | ||
| Vascular consequences of dietary salt intake | Q37298460 | ||
| Microalbuminuria is common, also in a nondiabetic, nonhypertensive population, and an independent indicator of cardiovascular risk factors and cardiovascular morbidity | Q39571547 | ||
| Mineralocorticoids, hypertension, and cardiac fibrosis | Q40337147 | ||
| Improved quality of life, blood pressure, and biochemical status following laparoscopic adrenalectomy for unilateral primary aldosteronism | Q43188295 | ||
| Primary aldosteronism--one picture is not worth a thousand words | Q43282857 | ||
| Renal damage in primary aldosteronism: results of the PAPY Study | Q43443868 | ||
| A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients | Q43565017 | ||
| High prevalence of primary aldosteronism in the Tayside hypertension clinic population. | Q44074818 | ||
| Aldosterone induces a vascular inflammatory phenotype in the rat heart | Q44182980 | ||
| Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64). | Q44242786 | ||
| Aldosterone/salt induces renal inflammation and fibrosis in hypertensive rats | Q44390510 | ||
| Primary aldosteronism and hypertensive disease | Q44471490 | ||
| Nongenomic vascular action of aldosterone in the glomerular microcirculation | Q44560788 | ||
| High rate of detection of primary aldosteronism, including surgically treatable forms, after ???non-selective??? screening of hypertensive patients | Q44642155 | ||
| Rapid inhibition of vasoconstriction in renal afferent arterioles by aldosterone. | Q44654274 | ||
| Active renin versus plasma renin activity to define aldosterone-to-renin ratio for primary aldosteronism | Q44838802 | ||
| Primary aldosteronism--careful investigation is essential and rewarding | Q44889507 | ||
| Rapid screening test for primary hyperaldosteronism: ratio of plasma aldosterone to renin concentration determined by fully automated chemiluminescence immunoassays | Q44973115 | ||
| Fasting plasma glucose and serum lipids in patients with primary aldosteronism: a controlled cross-sectional study | Q46120242 | ||
| Aldosterone and metabolic dysfunction: an unresolved issue | Q46120249 | ||
| Relative glomerular hyperfiltration in primary aldosteronism | Q46412561 | ||
| Prevalence and characteristics of the metabolic syndrome in primary aldosteronism | Q46807615 | ||
| Cardiovascular outcomes in patients with primary aldosteronism after treatment | Q46808203 | ||
| Relation of dietary salt and aldosterone to urinary protein excretion in subjects with resistant hypertension | Q46845253 | ||
| The relationships of proteinuria, serum creatinine, glomerular filtration rate with cardiovascular disease mortality in Japanese general population | Q46963308 | ||
| Long-term cardiac effects of adrenalectomy or mineralocorticoid antagonists in patients with primary aldosteronism | Q46983529 | ||
| Plasma aldosterone is independently associated with the metabolic syndrome. | Q51496145 | ||
| Salt-induced increases in systolic blood pressure affect renal hemodynamics and proteinuria. | Q54171098 | ||
| Microalbuminuria in salt-sensitive patients. A marker for renal and cardiovascular risk factors. | Q54214520 | ||
| Cross-sectional relations of serum aldosterone and urine sodium excretion to urinary albumin excretion in a community-based sample | Q57073045 | ||
| Urinary Albumin Excretion Predicts Cardiovascular and Noncardiovascular Mortality in General Population | Q61965156 | ||
| Application of a radioimmunoassay for angiotensin I to the physiologic measurements of plasma renin activity in normal human subjects | Q68602093 | ||
| A Radioimmunoassay for Plasma Aldosterone1 | Q71506138 | ||
| A new genetic test for familial hyperaldosteronism type I aids in the detection of curable hypertension | Q72566478 | ||
| Response to unilateral adrenalectomy for aldosterone-producing adenoma: effect of potassium levels and angiotensin responsiveness | Q72712133 | ||
| Aldosterone: a mediator of myocardial necrosis and renal arteriopathy | Q73027730 | ||
| Primary aldosteronism | Q73506430 | ||
| Urinary sodium excretion and cardiovascular mortality in Finland: a prospective study | Q73666010 | ||
| Success of surgery for primary aldosteronism judged by residual autonomous aldosterone production | Q77643283 | ||
| Salt induces myocardial and renal fibrosis in normotensive and hypertensive rats | Q77648681 | ||
| Role of aldosterone in renal vascular injury in stroke-prone hypertensive rats | Q77945596 | ||
| Renal function in primary aldosteronism | Q79137188 | ||
| Salt loading produces severe renal hemodynamic dysfunction independent of arterial pressure in spontaneously hypertensive rats | Q80335393 | ||
| Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism | Q81661632 | ||
| Long-term renal outcomes in patients with primary aldosteronism | Q83987126 | ||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 592-599 | |
| P577 | publication date | 2010-11-11 | |
| P1433 | published in | Journal of Human Hypertension | Q15746469 |
| P1476 | title | Unilateral adrenalectomy improves urinary protein excretion but does not abolish its relationship to sodium excretion in patients with aldosterone-producing adenoma | |
| P478 | volume | 25 |
| Q38208961 | Aldosterone excess and resistant hypertension: investigation and treatment |
| Q30248429 | Primary Aldosteronism: Changing Definitions and New Concepts of Physiology and Pathophysiology Both Inside and Outside the Kidney |
| Q39553108 | The mitochondrial SIRT1-PGC-1α axis in podocyte injury |
Search more.